PROPENSITY SCORE ADJUSTED REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB VS. ANTI-TNF IN BIOLOGIC-NAÏVE CROHN´S DISEASE PATIENTS: INDUCTION PHASE RESULTS FROM THE PROSPECTIVE, OBSERVATIONAL VEDOIBD STUDY IN GERMANY

Bernd Bokemeyer  ¹     Sandra Plachta-Danielzik  ²     Romina di Giuseppe  ²     Philipp Efken  ³     Wolfgang Mohl  ⁴     Martin Hoffstadt  ⁵     Thomas Krause  ⁶     Axel Schweitzer  ⁷     Elisabeth Schnoy  ⁸     Raja Atreya  ⁹     Niels Teich  ¹⁰     Leo Trentmann  ¹¹     Robert Ehehalt  ¹²     Sina Franzenburg  ¹²     Petra Hartmann  ¹²     Stefan Schreiber  ^13    
1 Interdiscilinary Crohn Colitis Centre Minden, Minden, Germany
² Competence Network IBD, Kiel, Germany
³ Gastroenterology Practice Minden, Minden, Germany
⁴ Zentrum fur Gastroenterologie Saar MVZ GmbH, Saarbrücken, Germany
⁵ Medizinisches Versorgungszentrum Dres. Hoffstadt, Iserlohn, Germany
⁶ Gastroenterology Practice Kassel Opernstraße, Kassel, Germany
⁷ Gastroenterologische Gemeinschaftspraxis am Germania Campus, Münster, Germany
⁸ Universitätsklinikum Augsburg, Augsburg, Germany
⁹ University Erlangen-Nuremberg, Erlangen, Germany
¹⁰ Gastroenterology Practice Leipzig, Leipzig, Germany
¹¹ Gastroenterology Practice Bremen, Bremen, Germany
¹² Praxis für Gastroenterologie Prof. Dr. R. Ehehalt, Heidelberg, Germany
¹³ Universität Kiel UKSH Medizinische Abt. I, Kiel, Germany

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)